1. Home
  2. UAMY vs BNTC Comparison

UAMY vs BNTC Comparison

Compare UAMY & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • BNTC
  • Stock Information
  • Founded
  • UAMY 1968
  • BNTC 1995
  • Country
  • UAMY United States
  • BNTC United States
  • Employees
  • UAMY N/A
  • BNTC N/A
  • Industry
  • UAMY Metal Fabrications
  • BNTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • UAMY Industrials
  • BNTC Health Care
  • Exchange
  • UAMY Nasdaq
  • BNTC Nasdaq
  • Market Cap
  • UAMY 74.2M
  • BNTC 88.1M
  • IPO Year
  • UAMY N/A
  • BNTC N/A
  • Fundamental
  • Price
  • UAMY $1.93
  • BNTC $11.90
  • Analyst Decision
  • UAMY Strong Buy
  • BNTC Buy
  • Analyst Count
  • UAMY 2
  • BNTC 6
  • Target Price
  • UAMY $1.75
  • BNTC $23.83
  • AVG Volume (30 Days)
  • UAMY 7.2M
  • BNTC 52.1K
  • Earning Date
  • UAMY 11-12-2024
  • BNTC 02-11-2025
  • Dividend Yield
  • UAMY N/A
  • BNTC N/A
  • EPS Growth
  • UAMY N/A
  • BNTC N/A
  • EPS
  • UAMY N/A
  • BNTC N/A
  • Revenue
  • UAMY $10,219,826.00
  • BNTC N/A
  • Revenue This Year
  • UAMY N/A
  • BNTC N/A
  • Revenue Next Year
  • UAMY N/A
  • BNTC N/A
  • P/E Ratio
  • UAMY N/A
  • BNTC N/A
  • Revenue Growth
  • UAMY 28.40
  • BNTC N/A
  • 52 Week Low
  • UAMY $0.17
  • BNTC $2.69
  • 52 Week High
  • UAMY $2.35
  • BNTC $13.29
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 74.22
  • BNTC 62.51
  • Support Level
  • UAMY $1.90
  • BNTC $11.36
  • Resistance Level
  • UAMY $2.35
  • BNTC $13.29
  • Average True Range (ATR)
  • UAMY 0.32
  • BNTC 0.96
  • MACD
  • UAMY 0.09
  • BNTC 0.23
  • Stochastic Oscillator
  • UAMY 83.60
  • BNTC 86.05

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Share on Social Networks: